Skip to content

A Study of the Effects of Intake of Two Cod Residual Meals on Glucose Regulation in Overweight and Obese Adults

An 8 Week Study to Compare the Effects of Two Combinations of Water Soluble and Non-water Soluble Cod Residual Meals on Glucose Regulation in Overweight and Obese Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01894542
Acronym
FISK4
Enrollment
55
Registered
2013-07-10
Start date
2013-08-31
Completion date
2019-12-31
Last updated
2022-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Overweight

Brief summary

The investigators have previously shown the intact protein from cod filet improves glucose regulation and serum lipid profile in overweight adults. A large amount of trimmings from various fish species such as cod is thrown away or sold at very low prices for animal feed, and analyses of the amino acid composition reveals that this can be a good protein source for humans. Two fractions are normally isolated from intact fish meal, i.e. water soluble and non-water soluble proteins. In the present study the investigators will compare these fractions, by studying their effects on glucose regulation in overweight/obese adults.

Detailed description

Participants receive 6g per day of water soluble on non-water soluble cod protein as tablets for 8 weeks.

Interventions

DIETARY_SUPPLEMENTCod protein from presscake

6g protein per day for 8wk

DIETARY_SUPPLEMENTCod protein from presscake + stickwater

6 g protein per day for 8 wk

DIETARY_SUPPLEMENTControl

Sponsors

Granit AS Transport & Tourism
CollaboratorOTHER
Norwegian Seafood Center
CollaboratorUNKNOWN
Nofima
CollaboratorOTHER
University of Bergen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI\>28 * healthy * fasting blood glucose \<7.0 mmol/L * stable body weight with less than 5 kg fluctuation during the last 4 months

Exclusion criteria

* known disease or metabolic disturbances related to overweight or obesity * use of prescription medications that affect blood glucose, blood lipids or inflammatory status * allergies towards fish or seafood * undertaking a weight loss diet * tobacco use exceeding \>15 cigarettes/day * pregnancy or breastfeeding * high seafood consumption * use of dietary supplements including cod liver oil or other marine fatty acids * allergies towards fish, milk, egg

Design outcomes

Primary

MeasureTime frameDescription
Glucose tolerance8 weeksSerum glucose will be measured in fasting and postprandial state

Secondary

MeasureTime frameDescription
Gene expression8 weeksChanges in gene expression in adipose tissue related to the circulating markers of glucose regulation.
Amino acids and amino acid metabolites8 weeksAmino acids and amino acid metabolites will be measured in serum and urine
Comparisons of metabolites and co-factors involved in one-carbon metabolism in serum and urine8 weeksConcentrations of relevant metabolites and co-factors were measured in serum and urine

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026